Molecular Features of HPV-Independent Cervical Cancers
Authors:
- Luca GiannellaLGLuca Giannella
- Camilla GrelloniCGCamilla Grelloni
- Leonardo NataliniLNLeonardo Natalini
- Gianmarco SartiniGSGianmarco Sartini
- Mila BordiniMBMila Bordini
- Giovanni Delli CarpiniGiovanni Delli Carpini
- Jacopo Di GiuseppeJGJacopo Di Giuseppe
- Erica DugoEDErica Dugo
- Francesco PivaFPFrancesco Piva
- Andrea CiavattiniAndrea Ciavattini
Open Access
Abstract
HPV-independent cervical cancers represent a small proportion of these types of cancers, predominantly glandular lesions. It should be noted that some cases may depend on diagnostic problems that lead to false negative cases. However, the most recent classifications distinguish cervical tumors into HPV-associated and HPV-independent cancers. HPV-negative cervical carcinomas (5–11% of all cases) mainly include rare adenocarcinomas (gastric, mesonephric, clear, serous, and endometrioid) and present distinct clinical and molecular features. These tumors usually affect older women and are diagnosed at more advanced stages than HPV-positive tumors, with an overall worse prognosis. This concerning and notably worse prognosis highlights the need for further research and understanding. Unlike HPV-positive carcinomas (which depend on the viral oncogenes E6/E7), HPV-independent tumors accumulate genomic mutations that activate oncogenes and inactivate suppressor genes. Therefore, a comprehensive overview of these aspects can be the key to a better understanding and developing personalized treatments. In the present review, the main mutated genes, the signaling pathways involved, the differences from HPV-positive tumors, the distinctive immunohistochemical markers, and the diagnostic and therapeutic implications are explored in depth.Keywords
This publication has 69 references indexed in Scilit:
- An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and ClassificationThe Journal of Pathology: Clinical Research, 2020
- Cytomorphology of Gastric‐Type Cervical Adenocarcinoma on a ThinPrep Pap Test: Report of a p16‐Positive Tumor CaseDiagnostic Cytopathology, 2016
- Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesionCancer Cytopathology, 2015
- Somatic mutation in PIK3CA is a late event in cervical carcinogenesisThe Journal of Pathology: Clinical Research, 2015
- Comparison of cervical cancer screening results among 256,648 women in multiple clinical practicesCancer Cytopathology, 2015
- Oncogenic mutations in cervical cancerCancer, 2013
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publicationInternational Journal of Cancer, 2010
- Different outcome of invasive cervical cancer associated with high‐risk versus intermediate‐risk HPV genotypeInternational Journal of Cancer, 2008
- The role of TP53 in Cervical carcinogenesisHuman Mutation, 2003
- Clear cell adenocarcinoma of the vagina and cervixCancer, 1997